Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $43.14 million. The enterprise value is -$38.47 million.
| Market Cap | 43.14M |
| Enterprise Value | -38.47M |
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.09 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 41.09M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 6.51% |
| Owned by Institutions (%) | 16.56% |
| Float | 20.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.04, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.04 |
| Quick Ratio | 4.66 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.12% and return on invested capital (ROIC) is -33.60%.
| Return on Equity (ROE) | -52.12% |
| Return on Assets (ROA) | -30.17% |
| Return on Capital (ROIC) | -33.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$311,065 |
| Employee Count | 215 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $485,000 in taxes.
| Income Tax | 485,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.10% in the last 52 weeks. The beta is 1.34, so ACHL's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +32.10% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 64.26 |
| Average Volume (20 Days) | 141,188 |
Short Selling Information
| Short Interest | 159,245 |
| Short Previous Month | 212,546 |
| Short % of Shares Out | 0.63% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.93M |
| Pretax Income | -64.01M |
| Net Income | -66.88M |
| EBITDA | -67.25M |
| EBIT | -71.93M |
| Earnings Per Share (EPS) | -$1.66 |
Balance Sheet
The company has $86.05 million in cash and $3.62 million in debt, giving a net cash position of $82.43 million or $2.01 per share.
| Cash & Cash Equivalents | 86.05M |
| Total Debt | 3.62M |
| Net Cash | 82.43M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 103.14M |
| Book Value Per Share | 2.51 |
| Working Capital | 93.16M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.45% |
| Shareholder Yield | -1.45% |
| Earnings Yield | -152.12% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ACHL is $2.83, which is 169.52% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.83 |
| Price Target Difference | 169.52% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 17.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |